Ong EZ, Kalimuddin S, Chia WC, Ooi SH, Koh CWT, Tan HC, Zhang SL, Low JG, Ooi EE, Chan KR*(2021). Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution, EBioMedicine, 65, 103262.
Chan CYY, John JZH, Gan ES, Ong EZ, Zhang SL, Tan HC, Chai X, Ghosh S, Ooi EE, Chan KR (2019). Antibody-dependent dengue virus entry modulates cell intrinsic responses for enhanced infection. mSphere, 4, 5.
Chan KR, Gan ES, Chan CY, Liang C, Low JZ, Zhang SL, Ong EZ, Bhatta A, Wijaya L, Lee YH, Low JG, Ooi EEE (2019). Metabolic perturbations and cellular stress underpin susceptibility to symptomatic live attenuated yellow fever infection. Nature Medicine, 25, 8, 1218-1224.
Tharakaraman K, Watanabe S, Chan KR, Huan J, Subramanian V, Chionh YH, Raguram A, Quinlan D, McBee M, Ong EZ, Gan ES, Tan HC, Tyagi A, Bhushan S, Lescar J, Vasudevan SG, Ooi EE, Sasisekharan R (2018). Rational design and characterisation of a Zika virus neutralising antibody that targets a quaternary epitope. Cell Host Microbe, 23, 5, 618-627
Kwek SS, Watanabe S, Chan KR, Ong EZ, Tan HC, Ng WC, Nguyen MTX, Gan ES, Zhang SL, Chan KWK, Tan JH, Sessions OM, Manuel M, Pompon J, Chua C, Hazirah S, Tryggvason K, Vasudevan SG, Ooi EE (2018). A systemic approach to the development of a safe live attenuated Zika vaccine, Nat Commun, 9, 1, 1031.
Chan CY, Chan KR**, Chua CJ, Nur Hazirah S, Ghosh S, Ooi EE (2017). Early molecular correlates of adverse events following yellow fever vaccination. JCI Insight, 2, 19. **Co-first author.
Gan ES, Cheong WF, Chan KR, Ong EZ, Chai X, Tan HC, Ghosh S, Wenk MR, Ooi EE (2017). Hypoxia enhances antibody-dependent dengue virus infection. EMBO J, 36,10,1348-63.
Chan KR, Wang XH, Saron WAA, Gan ES, Tan HC, Mok DZ, Zhang SL, Lee YH, Liang C, Wijaya L, Ghosh S, Cheung YB, Tannenbaum SR, Abraham SN, St John AL, Low JG, Ooi EE (2016). Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity. Nat Microbiol, 1, 16164.
Robinson LN, Tharakaraman K, Rowley KJ, Costa VV, Chan KR, Wong YH, Ong LC, Tan HC, Koch T, Cain D, Kirloskar R, Viswanathan K, Liew CW, Tissire H, Ramakrishnan B, Myette JR, Babcock GJ, Sasisekharan V, Alonso S, Chen J, Lescar J, Shriver Z, Ooi EE, Sasisekharan R (2015). Structure-guided design of an anti-dengue antibody directed to a non-immunodominant epitope. Cell, 162, 493-504.
Chan KR, Ong EZ, Tan HC, Zhang SL, Zhang Q, Tang KF, Kaliaperumal N, Lim AP, Hibberd ML, Chan SH, Connolly JE, Krishnan M, Lok SM, Hanson BJ, Lin CN, Ooi EE (2014). Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue. Proc Natl Acad Sci USA, 111, 2722-7.